Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention

BACKGROUND: Although there have been several studies related to serum fibroblast growth factor 21 (FGF21) levels and acute myocardial infarction, the value of serum FGF21 levels in ST-segment elevation myocardial infarction (STEMI) patients after emergency percutaneous coronary intervention (PCI) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Lingyun, Jiang, Wenlong, Qian, Huidong, Zheng, Ruolong, Li, Weizhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487623/
https://www.ncbi.nlm.nih.gov/pubmed/34703671
http://dx.doi.org/10.7717/peerj.12235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487623/
https://www.ncbi.nlm.nih.gov/pubmed/34703671
http://dx.doi.org/10.7717/peerj.12235

Ejemplares similares